Preclinical models demonstrate that RAS(ON) multi-selective inhibition reduces tumor growth in PDAC, suggesting T-cell involvement.
Supplementary Figure S1: RAS(ON) multi-selective inhibition inhibits PDAC growth in implanted tumor models
No takes yet. Share an insight, caveat, or question.
Orlen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: